HTCL-DDI: a hierarchical triple-view contrastive learning framework for drug–drug interaction prediction
Briefings in Bioinformatics · 22.09.2023 · 24 (6)
DOI: 10.1093/bib/bbad324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 22.09.2023. Verfasst von Ran Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Computer Network Information Center, Chinese Academy of Sciences, Beijing, 100083, China. Hauptthemen laut MEDLINE: Deep Learning. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Chinese Academy of Sciences, Informatization Plan of Chinese Academy of Sciences.
Abstract (Originalsprache)
Drug–drug interaction (DDI) prediction can discover potential risks of drug combinations in advance by detecting drug pairs that are likely to interact with each other, sparking an increasing demand for computational methods of DDI prediction. However, existing computational DDI methods mostly rely on the single-view paradigm, failing to handle the complex features and intricate patterns of DDIs due to the limited expressiveness of the single view. To this end, we propose a Hierarchical Triple-view Contrastive Learning framework for Drug–Drug Interaction prediction (HTCL-DDI), leveraging the molecular, structural and semantic views to model the complicated information involved in DDI prediction. To aggregate the intra-molecular compositional and structural information, we present a dual attention-aware network in the molecular view. Based on the molecular view, to further capture inter-molecular information, we utilize the one-hop neighboring information and high-order semantic relations in the structural view and semantic view, respectively. Then, we introduce contrastive learning to enhance drug representation learning from multifaceted aspects and improve the robustness of HTCL-DDI. Finally, we conduct extensive experiments on three real-world datasets. All the experimental results show the significant improvement of HTCL-DDI over the state-of-the-art methods, which also demonstrates that HTCL-DDI opens new avenues for ensuring medication safety and identifying synergistic drug combinations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Computer Network Information Center, Chinese Academy of Sciences, Beijing, 100083, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
Förderung
- Chinese Academy of Sciences
- Informatization Plan of Chinese Academy of Sciences
Zitieren
APA
Zhang, R., Wang, X., Wang, P., Meng, Z., Cui, W., & Zhou, Y. (2023). HTCL-DDI: a hierarchical triple-view contrastive learning framework for drug–drug interaction prediction. Briefings in Bioinformatics, 24(6). https://doi.org/10.1093/bib/bbad324
Vancouver
Zhang R, Wang X, Wang P, Meng Z, Cui W, Zhou Y. HTCL-DDI: a hierarchical triple-view contrastive learning framework for drug–drug interaction prediction. Briefings in Bioinformatics. 2023;24(6). doi:10.1093/bib/bbad324
BibTeX
@article{Zhang2023,
author = {Zhang, Ran and Wang, Xuezhi and Wang, Pengfei and Meng, Zhen and Cui, Wenjuan and Zhou, Yuanchun},
title = {HTCL-DDI: a hierarchical triple-view contrastive learning framework for drug–drug interaction prediction},
journal = {Briefings in Bioinformatics},
year = {2023},
volume = {24},
number = {6},
doi = {10.1093/bib/bbad324}
}
EUVIMED